Intersect ENT (XENT)

Earnings in 2021: -€0.15 Billion

According to Intersect ENT's latest financial reports the company's current earnings are €0.10 Billion. In 2021 the company made an earning of -€0.15 Billion a decrease over its 2020 earnings that were of -€66.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intersect ENT from 2012 to 2021

Annual earnings

Year	Earnings	Change
2021	-€0.15 Billion	121.8%
2020	-€66.35 Million	69.17%
2019	-€39.22 Million	87.57%
2018	-€20.91 Million	40.08%
2017	-€14.93 Million	-35.12%
2016	-€23.01 Million	-5.3%
2015	-€24.3 Million	45.05%
2014	-€16.75 Million	-0.04%
2013	-€16.76 Million	12.25%
2012	-€14.93 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Ocular Therapeutix OCUL	-€0.18 Billion	19.95%	🇺🇸 USA
Anika Therapeutics ANIK	-€4.66 Million	-96.84%	🇺🇸 USA
Haemonetics HAE	€0.16 B	-211.84%	🇺🇸 USA
ICON plc ICLR	€0.79 B	-638.78%	🇮🇪 Ireland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Intersect ENT (XENT)

Earnings in 2021: -€0.15 Billion